@misc{indiciaef6dec8ed8c82,
  title = {Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.},
  author = {Lephart, P. R. and Bachman, M. A. and LeBar, W. and McClellan, S. W. and Barron, K. and Schroeder, L. and Newton, D. W.},
  year = {2020},
  doi = {10.1101/2020.06.04.135616},
  url = {https://www.biorxiv.org/content/10.1101/2020.06.04.135616v1},
  note = {Source identifier: 10.1101/2020.06.04.135616}
}